This Week’s Science Headlines January 31, 2014 / Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Product Liability Regulatory / Life Science Matters Litigation Byetta Thyroid Cancer Lawsuit Centralization Request Filed with JPML MDL Arguments Over Centralization of Lipitor Diabetes Cases Postponed Top DOJ Atty Outline Pharma Fraud Enforcement (subscription required) Possible Sanctions for Takeda in Actos Bladder Cancer MDL (subscription required) Hydroxycut False Ad Claims Must Be Clarified, Judge Says (subscription required) GNC Hit with Suit Claiming Diet Pills Led to Liver Damage (subscription required) J&J Beats $258M Risperdal Verdict in Split La. High Court (subscription required) Calif. Court Reverses Preemption of Medtronic Injury Suit (subscription required) 4th Circ. Tosses Generic-Drug Injury Appeal Against Pliva (subscription required) Master Complaint for Stryker Rejuvenate Hip Lawsuits Approved Zimmer NexGen Knee Lawsuits to be Selected for First Case Picks in MDL DePuy Just Can’t Shake Those Hip Replacement Lawsuits (subscription required) Actos Bellwether Trial Set to Begin in MDL 3rd Circ. To Review Venue Ruling in GSK Birth Defects Cast (subscription required) 7th Circ. Reverses Boehringer Depo Order in Pradaxa MDL (subscription required) St. Jude Can’t Shake Defective Defibrillator Suits (subscription required) 6th Circ. Won’t Rehear Generic-Reglan Injury Claims (subscription required) Pradaxa Bellwether Lawsuits Selected for First Trial Dates in MDL Byetta, Januvia Litigation Being Coordinated Between Federal, State Court Pa. Pharma Ruling Opens New Front in Mass Tort Battles (subscription required) Regulatory What Attorneys Should Know about FDA’s MedWatch Data (subscription required) FDA Scolds Texas Drugmaker Over STD Product Promos (subscription required) Premarket Approval (PMA) Summary Review Memos for 180-Day Design Changes “Natural” Labeling Row Remains FDA’s Domain Gruma Says (subscription required) J&J Urges FDA Deference In Baby Wash False Ad Action (subscription required) What’s In The Wash? FDA Rules On Antibacterial Soaps (subscription required) Improving the Quality of Abbreviated New Drug Application Submissions to the Food and Drug Administration, Establishment of a Public Docket Another Ranbaxy Drug Plant Fails FDA Test GOP Lawmakers Rip FDA’s Generic-Drug Labeling Overhaul (subscription required) For a look at last week’s life science headlines, click here. Life Science Matters
This Week’s Science Headlines
Litigation
Regulatory
For a look at last week’s life science headlines, click here.
Life Science Matters
Next ArticleNew Alternative Causation for Pharma Defendants in Surgeon General's Smoking Report?